uses nano-particles in vaccines are not tested for H1N1 influenza vaccines
approved by the competent government authorities for vaccination against swine flu H1N1 were supposed to contain nanoparticles. Manufacturers have experimented with the nanoparticles as a way of "supercharged" vaccines for a period of several years. But now it turns out that the vaccines approved for use in Germany and the European countries containing nanoparticles in a form that was attacking healthy cells and can be a deadly form.
In 2007, researchers from the 'Ecole Polytechnique Fédérale de Lausanne (EPFL) in an article published in the journal Nature Biotechnology, announced they have developed a "nanoparticle that can carry vaccines more efficiently, with fewer side effects and to a fraction of the cost of current technologies for vaccines. "
Article goes on to describe the effects of quantum leap in: "At just 25 nanometers, these particles are so tiny that once injected, swim in the extracellular matrix of the skin and lymph nodes are of yarn. Within a few minutes away from a concentration of cells thousands of times greater than in the skin. The immune response can then be extremely strong and effective. " [1] There is only one small problem with vaccines that contain nanoparticles:
can be fatal or at least cause irreparable damage to health.
Nanoparticles, by the means of mass communication line as a wonderful revolution in science, are particles already put into production, much smaller than the deadly asbestos particles that, before being outlawed, have caused serious lung damage and death.
nanoscale particles (1 nm = 0.000000001 meter), were combined with the membranes of our body and, according to recent studies conducted in China and Japan, once introduced into the body, go on to destroy the cells continuously . Once they have interacted with the cellular structure of the body can no longer be removed.
Modern medicine euphemistically called this phenomenon a 'reaction continues infectious'.
After the asbestos scandal, has been established that particle size of less than one millionth of a meter - because of their enormous power of attraction - penetrate all the cells by destroying all those with whom they come into contact, and the nanoparticles are much smaller asbestos fibers.
The fact that the WHO, the European Medicines Evaluation Agency, and Germanium Robert Koch Institute and other medical institutions now allow the population to be injected with vaccines containing nanoparticles largely untested, says the longer the power of the pharmaceutical lobby European policies but also on moral and professional integrity of those civil servants, public health officials.
The September 2009 issue of the listed European Respiratory Journal, August 19 made public - and available online until 21 August - the contents of an article recommended by colleagues and with the title: "Exposure to nanoparticles is correlated with the pleural effusion, pulmonary fibrosis and granuloma."
Article describes experiments carried out in 2008 on seven young women, selected at the Beijing Chaoyang Hospital. All seven, aged between 18 and 47, were exposed to nanoparticles for a period of 5 to 13 months, in their place of work. All were admitted to hospital with dyspnea and pleural effusion, or excess fluid in the lungs that caused excess breath. None of the seven had never smoked and was not part of some specific group risk. The doctors
condoto carefully all the examinations of the case and confirmed that the lung problems share a common etiology: the regular breathing of nanoparticles at their companies.
In fact they were all were exposed to inhalation of nanoparticles Polyacrylate.
Tests have confirmed that the nanoparticles in patients who had created a "super-reaction-of-fusion." Despite all the heroic efforts of medical staff, two of the seven women have died from pulmonary complications. [2]
in their reports. scientists come to conclusions so alarming that it is necessary to quote them in full:
"immunological tests were conducted, bacteriological and virological studies of tumor markers, bronchoscopy, thoracoscopy and internal video-assisted thoracic surgery. Surveys were conducted in the workplace, clinical observations and examinations of patients. E 'confirmed the presence of Polyacrylate - made up of nanoparticles - in the workplace.
pathologic examination of lung tissue of patients had nonspecific pulmonary inflammation, pulmonary fibrosis and foreign-body granulomas in the pleura. Using transmission electron microscopy, the nanoparticles were observed in the cytoplasm and which fall in carioplasma epithelial cells and mesothelial lung, but also in the thoracic fluid. This has aroused concern that prolonged exposure to nanoparticles - without protective measures - can be linked to serious damage to the lungs of man. "[3]
Currently, animal studies and in vitro experiments show that nanoparticles may cause lung damage and other effects toxic to animals, but before the search of Beijing, was not produced any report on the clinical toxicity in humans.
Research of Beijing Chaoyang Hospital, has now definitively confirmed that nanoparticles cause lung damage and other toxic effects even in humans.
Currently, as two of the vaccines approved and scheduled for mass distribution - in Germany and elsewhere - contain nanoparticles, the loss of qualified officials and leaders of public health and epidemiology who have not ordered an immediate freeze on distribution of any vaccine containing nanoparticles, can only be considered equivalent to a criminal negligence.
We hope that the authorities in charge to react in time to avoid a possible health catastrophe whose magnitude would be far greater than the worst scenario of swine flu now reported.
F. William Engdahl
Source> Global Research That can deliver vaccines more Effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies, accessed in www.azonano.com /% 20news.asp nanotechnology? catid = 13.
2] Song Y, Li X, Du X, Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma, European Respiratory Journal, 9 / 2009, 34 (3): 559-567.
3] Ibid.
0 comments:
Post a Comment